Eli Lilly 'aggressively planning' manufacturing expansions, CEO says, as Mounjaro soars
Fierce Pharma
NOVEMBER 2, 2023
Supply problems for Eli Lilly’s diabetes med Mounjaro were no secret. As strong demand continues to push Mounjaro sales to new highs, Eli Lilly CEO David Ricks said the company is "not done with" manufacturing expansions.
Let's personalize your content